Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2021;32(2):168-73
Article Links
Ergotamine Induced Retroperitoneal Fibrosis
Susama Patra1, Somanath Padhi1, Prasanta Padhan2, Madhabananda Kar3, Prasant Nayak4, Subash Chandra Samal5
Authors Information

1. Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
2. Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneshwar, Odisha, India
3. Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
4. Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
5. Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India

Padhan P, Kar M, Nayak P 

Keywords: RPF, vasculitis, ergotamine
References
  1. Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis – the state-of-the-art. Reumatologia 2016;5:256-63.
  2. Brandt AS, Kamper L, Kukuk S, Haage P, Roth S. Associated findings and complications of retroperitoneal fibrosis in 204 patients: results of a urological registry. J Urol 2011;185:526-31.
  3. Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009;33:1833-9.
  4. Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol 2008;191:423-31.
  5. Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR,et al. Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up. Radiographics 2013;33:535-52.
  6. Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 2011;86:297-303.
  7. Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol 2016;27:1880-9.
  8. van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse ALHJ. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 2009;88:193-201.
  9. Palmisano A. Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009;23:339-53.
  10. Palmisano A, Urban ML, Corradi D, Cobelli R, Alberici F, Maritati F, et al. Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? Rheumatology (Oxford) 2015;54:2004-9.
  11. Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV, et al. Vasculitis of the gastrointestinal tract in chronic periaortitis. Medicine (Baltimore) 2011;90:28-39.
  12. Parums DV. The spectrum of chronic periaortitis. Histopathology 1990;16:423-31.
  13. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990;114:383-7.
  14. Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006;55:126-30.
  15. Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol 2011;23:1-6.
  16. Salvarani C, Calamia KT, Crowson CS, Miller DV, Broadwell AW, Hunder GG, et al. Localized vasculitis of the gastrointestinal tract: a case series. Rheumatology (Oxford) 2010;49:1326-35.
  17. Mishra DP, Patro P, Sharma A. Drug induced vasculitis. Indian J Rheumatol 2019;14:S3-S9.
  18. Alberti C. Drug-induced retroperitoneal fibrosis: short etiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. G Chir 2015;36:187-91.
  19. Pfitzenmeyer P, Foucher P, Dennewald G, Chevalon B, Debieuvre D, Bensa P, et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996;9:1013-9.